NCT05414760 (CLEAN) is a NA clinical trial of Womed Leaf in Asherman Syndrome, sponsored by Remko P. Bosgraaf.

Who is sponsoring NCT05414760?

NCT05414760 is sponsored by Remko P. Bosgraaf.

What drugs are being tested in NCT05414760?

Interventions in NCT05414760: Womed Leaf.

What condition does NCT05414760 study?

NCT05414760 studies Asherman Syndrome, Intrauterine Adhesion.

Is NCT05414760 still recruiting?

NCT05414760 is currently completed. Last updated 7 February 2024.

Last reviewed 2024-02-07 · How we verify

NCT05414760: CLEAN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluate Formation of IUAs After Third-generation Endometrial Ablation, With and Without Intrauterine Adhesion Barrier

Completed NA Last updated 7 February 2024

What this trial tests

NA trial testing Womed Leaf in Asherman Syndrome in 1 participant. Completed in 5 February 2024.

Timeline

11 November 2022

Primary endpoint
5 February 2024

5 February 2024

Quick facts

Lead sponsor	Remko P. Bosgraaf
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	1
Start date	11 November 2022
Primary completion	5 February 2024
Estimated completion	5 February 2024
Sites	2 locations across Netherlands

Drugs / interventions tested

Womed Leaf

Conditions studied

Asherman Syndrome — all drugs for Asherman Syndrome →
Intrauterine Adhesion — all drugs for Intrauterine Adhesion →

Sponsor

Remko P. Bosgraaf

Who can join

30 and older, female only, with Asherman Syndrome or Intrauterine Adhesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the formation of adhesions after third-generation endometrial ablation, with and without the intrauterine adhesion barrier.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Womed Leaf

Trials testing the same drug.

NCT04381728 — PREvention of Intrauterine Adhesion After Hysteroscopic Surgery With Novel deGradable Film · NA · completed

Other recruiting trials for Asherman Syndrome

Currently open trials in the same condition.

NCT04671914 — Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester. · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05414760 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Remko P. Bosgraaf
Last refreshed: 7 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05414760.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing